The Androgen Replacement Therapy Market, estimated at USD 2,646.1 Mn in 2025, is expected to exhibit a CAGR of 7.8% and reach USD 4,476.5 Mn by 2032.
The market growth is driven by increasing demand for innovative and effective drugs across diverse therapeutic areas. Advances in drug discovery, biopharmaceuticals, and digital technologies are improving treatment outcomes and operational efficiency. Supportive regulations, rising R&D investments, and a strong focus on patient-centric care are creating new opportunities for pharmaceutical companies.
The increasing regulatory approvals for pharmaceutical products can drive the growth of the global androgen replacement therapy market over the forecast period. For instance, in November 2020, Aleor Dermaceuticals (A subsidiary of Alembic Pharmaceuticals Limited). an India-based multinational pharmaceutical company headquartered in State of Vadodara, received tentative approval from the U.S. Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Testosterone Gel, 1.62 %.
Global Androgen Replacement Therapy Market– Impact of Coronavirus (COVID-19) Pandemic
The World Health Organization (WHO) designated the illness caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which first appeared in Wuhan (province of Hubei, China) in the last months of 2019 as "coronavirus disease 2019" or COVID-19. This virus spread quickly and had a serious negative impact on the economies, social behaviors, and healthcare of every country in the world.
COVID-19 affected the economy in three main ways: by directly affecting production and demand, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to the lockdown, several countries such as India, China, Brazil, and others faced problems with regard to the transportation of drugs from one place to another.
COVID-19 had a negative e impact on the global androgen replacement therapy market. This was caused due to the increasing demand to develop and manufacture COVID- 19 vaccines and the simultaneous doubling of testosterone prescriptions since 2020. According to a report published In April 2020, by American Society of Health-System Pharmacists, an organization that represents pharmacists who serve as patient care providers in hospitals, health systems, ambulatory clinics, and other healthcare settings, stated that synthetic testosterone (testosterone cypionate) suppliers Cipla Inc., Hikma Pharmaceuticals PLC, and Sun Pharmaceutical Industries Ltd faced chronic shortages in testosterone drug supply since March 2020.
Global Androgen Replacement Therapy Market: Key Developments
Strategies like research and development activities is expected to boost market growth during the forecast period.
For instance, according to an article published in Singapore Medical Journal, the monthly publication of Singapore Medical Association, on January 19, 2023, testosterone replacement therapy has the potential to be used as a useful adjunct to standard rehabilitation in enhancing functional recovery in critically ill patients. Use of testosterone replacement therapy showed better grip strength in the rehabilitation of patients with intensive care unit-associated weakness and hospital-associated deconditioning.